Paul Simms has spent more than two decades creating the conversations that push life sciences forward. In 2003 he founded eyeforpharma, which grew into one of the industry’s most influential global event series before being acquired by Reuters in 2019. He later founded Impatient Health, an independent consultancy, research and events business for leaders who are dissatisfied with business as usual. Paul is known for challenging comfortable assumptions while keeping sight of what people must do next. His work spans the future of commercial strategy, Medical Affairs, customer leadership, launch, communication and the changing role of science in creating health outcomes. As an event organiser himself, Paul understands that a successful session begins well before he walks on stage. He works closely with organisers to understand the audience, shape the argument and create a presentation that belongs in that particular moment.